NIS-observe treatment efficacy in maintaining symptoms control in moderate/severe asthma with Symbicort SMART
Study identifier:NIS-RRO-SYM-2008/1
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
SMART way of treating asthma. Non-interventional study to evaluate clinical efficacy of Symbicort® Maintenance And Reliever Therapy (Symbicort® SMART) in the treatment of patients with moderate and severe asthma
Medical condition
Moderate/severe asthma
Phase
-
Healthy volunteers
No
Study drug
-
Sex
All
Actual Enrollment
1182
Study type
Observational
Age
18 Years +
Date
Study Start Date: 01 Nov 2008
Primary Completion Date: 01 Oct 2009
Study Completion Date: 01 Oct 2009
Study design
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verification:
Verified 01 Nov 2013 by AstraZeneca Pharmaceuticals
Sponsors
AstraZeneca Pharmaceuticals
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|---|
| 1 Moderate and severe asthma patients stabilized on Symbicort SMART | - |
Contacts
Investigators
Principal Investigator
Cristina Pentiuc
AstraZeneca
